EA200800070A1 - Производные 2-(1h-индолилсульфанил)ариламина - Google Patents

Производные 2-(1h-индолилсульфанил)ариламина

Info

Publication number
EA200800070A1
EA200800070A1 EA200800070A EA200800070A EA200800070A1 EA 200800070 A1 EA200800070 A1 EA 200800070A1 EA 200800070 A EA200800070 A EA 200800070A EA 200800070 A EA200800070 A EA 200800070A EA 200800070 A1 EA200800070 A1 EA 200800070A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indolylsulfanil
arylamine
derivatives
compounds
relates
Prior art date
Application number
EA200800070A
Other languages
English (en)
Russian (ru)
Inventor
Ян Келер
Карстен Юль
Мортен Банг Нергор
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200800070A1 publication Critical patent/EA200800070A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200800070A 2005-06-17 2006-06-14 Производные 2-(1h-индолилсульфанил)ариламина EA200800070A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69200905P 2005-06-17 2005-06-17
PCT/IB2006/002785 WO2006134499A2 (en) 2005-06-17 2006-06-14 2-(1h-indolylsulfanyl)-aryl amine derivatives

Publications (1)

Publication Number Publication Date
EA200800070A1 true EA200800070A1 (ru) 2008-04-28

Family

ID=37532681

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800070A EA200800070A1 (ru) 2005-06-17 2006-06-14 Производные 2-(1h-индолилсульфанил)ариламина

Country Status (15)

Country Link
EP (1) EP1893575B1 (cg-RX-API-DMAC7.html)
JP (1) JP5144507B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080027462A (cg-RX-API-DMAC7.html)
CN (1) CN101238101A (cg-RX-API-DMAC7.html)
AR (1) AR054394A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006257288A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611748A2 (cg-RX-API-DMAC7.html)
CA (1) CA2611566C (cg-RX-API-DMAC7.html)
EA (1) EA200800070A1 (cg-RX-API-DMAC7.html)
ES (1) ES2616095T3 (cg-RX-API-DMAC7.html)
IL (1) IL188064A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014954A (cg-RX-API-DMAC7.html)
NO (1) NO20080265L (cg-RX-API-DMAC7.html)
WO (1) WO2006134499A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710885B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540461A (ja) * 2007-09-24 2010-12-24 ハー・ルンドベック・アクチエゼルスカベット セロトニン二重作用化合物に関する併用療法
TW200938189A (en) * 2008-03-13 2009-09-16 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
EP2606031B1 (en) 2010-08-20 2017-09-27 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
US10179781B2 (en) * 2013-03-15 2019-01-15 Chromocell Corporation Sodium channel modulators for the treatment of pain
EP3046909A4 (en) 2013-09-17 2017-03-29 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
US9714240B2 (en) 2013-09-17 2017-07-25 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
PE20160654A1 (es) 2013-11-22 2016-07-15 Pharmakea Inc Compuestos de inhibidor de autotaxina
CN116059203A (zh) 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117129A (en) * 1976-10-22 1978-09-26 Warner-Lambert Company Indolobenzoxazepines as cns depressants
ATE195125T1 (de) * 1995-11-06 2000-08-15 Dsm Nv Verfahren zur de-esterifikation
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
TW200400177A (en) * 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
EP1701940B1 (en) * 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto

Also Published As

Publication number Publication date
AR054394A1 (es) 2007-06-20
BRPI0611748A2 (pt) 2016-11-22
KR20080027462A (ko) 2008-03-27
ZA200710885B (en) 2009-03-25
WO2006134499A3 (en) 2007-04-12
NO20080265L (no) 2008-01-15
JP5144507B2 (ja) 2013-02-13
WO2006134499A2 (en) 2006-12-21
MX2007014954A (es) 2008-02-15
CA2611566C (en) 2011-08-16
EP1893575B1 (en) 2017-01-11
ES2616095T3 (es) 2017-06-09
CA2611566A1 (en) 2006-12-21
EP1893575A2 (en) 2008-03-05
JP2008546679A (ja) 2008-12-25
CN101238101A (zh) 2008-08-06
AU2006257288A1 (en) 2006-12-21
IL188064A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
ECSP10010722A (es) Compuestos orgánicos
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов
EA201790678A1 (ru) Бициклические гетероарильные соединения
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
DK1761520T3 (da) Kinaseinhibitorer
NO20071127L (no) Triazoloftalaziner
EA201000269A1 (ru) Новые гербициды
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
ATE483000T1 (de) Naphtalin-amidin-imide
EA200601568A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
EA201000069A1 (ru) Новые гербициды
EA200801199A1 (ru) Ингибиторы киназы
EA201270630A1 (ru) Гетероциклические сетр ингибиторы
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4
DOP2005000010A (es) Inhibidores de quinasa
NO20082185L (no) Heterocykliske CETP-inhibitorer
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина